Atsena Secures FDA Fast Track Designation for ATSN-201 to Treat X-Linked Retinoschisis
With no approved treatments for XLRS, another promising gene therapy enters the fray. Atsena Therapeutics (North Carolina, USA) announced that…
Researchers Develop Head-Mounted Robotic System for Retinal Surgery
The retinal robot from the University of Utah’s John A. Moran Eye Center is capable of 1-micrometer movements. A team…
latest posts